Interferon beta-1a Withdrawn Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Supportive Care

IndicationsStatusPurposePhase
WithdrawnSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT02568111Brimonidine Tartrate for the Treatment of Injection Related Erythema